UBC13 Antibodies

Santa Cruz Biotechnology delivers a wide array of UBC13 monoclonal antibodies for investigating UBC13's role in cellular processes. UBC13 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).UBC13, a member of the ubiquitin-conjugating enzyme family, plays a critical role in the ubiquitin-proteasome system, which is essential for protein degradation and regulation of various cellular functions. UBC13 is particularly important in the formation of K63-linked polyubiquitin chains, which are involved in DNA repair, signal transduction, and immune responses. Understanding UBC13 is vital for elucidating its contributions to cellular homeostasis and disease mechanisms. Research has shown that UBC13 dysfunction can lead to various pathological conditions, making it an important target for therapeutic development. UBC13's involvement in DNA damage response pathways makes it particularly relevant for cancer research. Recent studies have highlighted UBC13's role in immune system regulation and inflammatory responses. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of UBC13's complex biological functions and potential therapeutic applications.